How do you think glaxo will perform against the NIFTY? Pick this stock
CAPITAL4 COMMUNITY
All: Members who that have picked this stock: 29
25 outperforms
4 underperforms
Stars: Top Investors who have picked this stock: 0
0 outperforms
0 underperforms
CLASSIFICATION | SECTOR | INDUSTRY |
|---|---|---|
| Primary | Pharma & Healthcare | Pharmaceuticals |
SNAPSHOT
- BSE Code / NSE Ticker
- 500660 / GLAXO
- Last traded time
- 2012-05-23 15:59:09
- Last traded on
- BSE
- Intra-day Low / High
- 1,953.0 / 2,013.0
- 52w closing Low / High
- 1,842.0 / 2,455.1
- Today Volume
- 10,243
- 30d avg Daily Volume
- 10,743
- Market Cap
- INR 16,598.2 cr
- P/E Ratio TTM
- 26.27
- Historical Performance
- Today
- Weekly
- Monthly
- 3 Months
- 1 Year
- -1.5%
- -3.4%
- -12.5%
- -3.4%
- -14.1%
valuation snapshotpeer comparisonfinancialsshare holdingmf holdingcommunity picksbrokerage picks futures & options
Top 10% Members' PicksAll Members' Picks
Active Picks OnlyClosed Picks OnlyAll Picks
| Member | Member Rating | Start Date | Call | Horizon | Start Price | Dividend Value | Stock Returns (A) | Index Returns (B) | Net points (A)-(B) | Comment |
|---|---|---|---|---|---|---|---|---|---|---|
| sunil05 | 0.0 | 18-May-12 |  |
1m | 2,069.95 | 0.00 | -5.33% | 0.28% | -5.61 | |
| PRATEEKJAS | 0.0 | 11-May-12 | |
1y to 2y | 2,050.00 | 0.00 | -4.41% | -2.48% | -1.93 | |
| renishv | 0.0 | 16-Apr-12 | |
3m | 2,200.00 | 0.00 | -10.93% | -7.12% | -3.80 | |
| forsudhi | 0.0 | 31-Jan-12 | |
6m | 1,922.05 | 45.00 | 4.30% | -6.32% | 10.62 | |
| amittal007 | 0.0 | 30-Dec-11 | |
3m | 1,950.00 | 45.00 | 2.80% | 2.95% | -0.15 | |
| iceycool | 0.0 | 21-Oct-11 | |
>5y | 2,105.00 | 45.00 | -4.77% | -4.79% | 0.02 | |
| maheshwarigk | 0.0 | 19-Sep-11 | |
1y | 2,080.00 | 45.00 | -3.62% | -4.24% | 0.61 | |
| luxcap | 0.0 | 28-Jul-11 | |
>5y | 2,305.00 | 45.00 | -13.03% | -12.44% | -0.59 | |
| PKS_stocks | 0.0 | 17-Mar-11 | |
6m | 2,080.25 | 45.00 | -3.63% | -12.18% | 8.54 | |
| jprinters | 0.0 | 26-Nov-10 | |
6m | 2,116.00 | 85.00 | -3.37% | -17.20% | 13.83 | |
| adpexim | 0.0 | 15-Nov-10 | |
6m | 2,230.00 | 85.00 | -8.31% | -20.40% | 12.09 | |
| dileepbajaj | 0.0 | 29-Sep-10 | |
6m | 2,234.00 | 85.00 | -8.48% | -19.99% | 11.51 | |
| modihar | 0.0 | 20-Sep-10 | |
6m | 2,026.00 | 85.00 | 0.92% | -18.74% | 19.66 | |
| rajdce | 0.0 | 25-Aug-10 |  |
6m | 1,942.00 | 85.00 | -5.29% | 12.38% | -17.67 | |
| dani | 0.0 | 14-May-10 | |
6m | 2,132.10 | 85.00 | -4.10% | -6.81% | 2.71 | |
| zyakaira | 0.0 | 04-Mar-10 | |
6m | 1,740.00 | 115.00 | 19.23% | -5.06% | 24.29 | |
| caniravkaria | 0.0 | 25-Feb-10 | |
6m | 1,722.00 | 115.00 | 20.48% | -0.61% | 21.09 | |
this is the safe stock but risky all depends upon economic scenario Reply | ||||||||||
| newuser | 0.0 | 24-Feb-10 | |
6m | 1,687.00 | 115.00 | 22.98% | -1.01% | 23.98 | |
| gargjeet | 0.0 | 02-Dec-09 | |
6m | 1,688.20 | 115.00 | 22.89% | -6.44% | 29.33 | |
| anuka777 | 0.0 | 12-Nov-09 | |
6m | 1,598.80 | 115.00 | 29.76% | -3.45% | 33.21 | |
BLUE CHIP FOREVER Reply | ||||||||||
| anuc77 | 0.0 | 14-Oct-09 | |
6m | 1,536.40 | 115.00 | 35.03% | -5.72% | 40.75 | |
| shintokk | 0.0 | 25-Sep-09 | |
1y to 2y | 1,578.30 | 115.00 | 31.45% | -2.82% | 34.27 | |
| darpanmago | 0.0 | 28-Aug-09 | |
1y | 1,394.65 | 115.00 | 48.76% | 2.29% | 46.47 | |
| prverma | 0.0 | 24-Aug-09 | |
1y | 1,422.40 | 115.00 | -45.86% | -3.61% | -42.24 | |
| shivrajsingh | 0.0 | 12-Aug-09 | |
6m | 1,385.90 | 115.00 | 49.70% | 8.69% | 41.01 | |
CAPITAL4 COMMUNITY
STOCK SCREENERS
INDIA CAPITAL MARKETS
GLAXO IN THE NEWS
- May-07 17:55 Glaxosmithkline Pharma net profit rises 26615.22% in the March 2012 quarter
- Feb-16 14:33 Glaxosmithkline Pharma net profit rises 18.18% in the December 2011 quarter
- Feb-16 13:02 GlaxoSmithKline Pharmaceuticals recommends dividend
- Feb-10 11:57 GlaxoSmithKline Pharmaceuticals to announce financial results
TOP BLOGS
- Advice for – Tuesday, May 22, 2012
by ABHISHEK-PARAKH
(Recommendations: 6) - Money can be made in all market conditions
by ASHOKSHARMA
(Recommendations: 7) - The problem with historical returns
by ROHIT CHAUHAN
(Recommendations: 9) - Markets: What next?
by Nishit_Vadhavkar
(Recommendations: 8) - Nifty – RSI at sub 30. Highly Oversold – Bottoming out in next few sessions
by NOORESH MERANI
(Recommendations: 9) - Follow up: Gujarat reclaim & rubber products ltd
by ROHIT CHAUHAN
(Recommendations: 9) - Negative news drags the markets down
by Nishit_Vadhavkar
(Recommendations: 7) - Option strategy worked will in such unpredictable market
by ASHOKSHARMA
(Recommendations: 8) - Sensex- Technical Outlook and Trading Levels, 8 April 2012
by D_Sathiamoorthy
(Recommendations: 5) - Insourcing vs. outsourcing government functions: A setback for public sector production of elementary education
by AJAY SHAH
(Recommendations: 7) - Crucial Week Ahead
by Nishit_Vadhavkar
(Recommendations: 8) - A few contrarian thoughts
by ROHIT CHAUHAN
(Recommendations: 8) - The Range Bound Trading continues
by Nishit_Vadhavkar
(Recommendations: 7) - Nifty Futures Technical Analysis - Intraday and Positional Trading calls, 27 April
by D_Sathiamoorthy
(Recommendations: 7) - Regulated cost of capital for airports
by AJAY SHAH
(Recommendations: 8)
Company and Mutual Fund Finder
| Company: | 3ABCDEFGHIJKLMNOPQRSTUVWXYZ |
| Indices: | NIFTY | SENSEX | BSE 100 | BSE 200 | BSE 500 | BSE MIDCAP | BSE SMALLCAP | BSE AUTO | BSE BANKEX | BSE CD | BSE CG | BSE FMCG | BSE HC | BSE IT | BSE METAL | BSE OIL | BSE POWER | BSE PSU | BSE REALTY | BSE TECK | BSE DOLLEX | DOLLEX 100 | DOLLEX 200 | NIFTY JUNIOR | CNX MIDCAP | NIFTY MID50 | BANK NIFTY | CNX IT | CNX100 | CNX 500 | CNX DEFTY |
| Mutual Funds: | AIG Global Investment | AXIS | Baroda Pioneer | Benchmark | Bharti AXA | Birla Sun Life | Canara Robeco | Deutsche | DSP BlackRock | Edelweiss | Escorts | Fidelity | Fortis | Franklin Templeton | HDFC | HSBC | ICICI Prudential | IDBI | IDFC | ING | JM Financial | JP Morgan | Kotak Mahindra | L&T | LIC | Mirae Asset | Morgan Stanley | Motilal Oswal | Peerless | Pramerica | PRINCIPAL | Quantum | Reliance | Religare | Sahara | SBI | Shinsei | Sundaram BNP Paribas | Tata | Taurus | UTI |